Brief: Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting
06/01/2026 14:11
Jan 6 (Reuters) - Ernexa Therapeutics Inc ERNA.O: ERNEXA THERAPEUTICS ANNOUNCES SUCCESSFUL PRE-IND FDA MEETING AND CONTINUES PROGRESS TOWARD FIRST-IN-HUMAN TRIAL IN OVARIAN CANCER ERNEXA THERAPEUTICS INC - ON TRACK TO INITIATE FIH TRIAL FOR OVARIAN CANCER IN 2026 Source text: ID:nGNX1j4X05 Further company coverage: ERNA.O ((Reuters.Briefs@thomsonreuters.com;))